Medical Devices Startups

Madorra develops a nonhormonal, noninvasive medical device to treat vaginal dryness and vulvovaginal atrophy, targeting post-menopausal people and breast cancer survivors. The company operates in the women's health medical device sector and has received FDA breakthrough device designation.

4 investors

Magnolia Medical develops diagnostic devices to reduce blood culture contamination and false-positive sepsis test results for hospitals and healthcare systems. Its FDA 510(k)-cleared Steripath initial specimen diversion technology is used by clinical care teams to improve diagnostic accuracy for sepsis testing, primarily in the U.S.

4 investors

MC10 developed conformal BioStamp wearable sensors and clinical analytics for physiological data capture in clinical research.

4 investors

Medcura develops hemostatic products made from hydrophobically modified biopolymers to control minimal, mild, and moderate surgical bleeding through mechanical mucoadhesion. Its offerings target surgeons, patients, and payers in the surgical hemostasis market, including specialized applications such as spine surgery.

4 investors

MEDZOOMER operates an on-demand prescription delivery platform that connects patients with pharmacies to enable remote access to medications. The service is designed for pharmacies, delivery partners, and patients seeking secure, compliant prescription fulfillment and delivery.

4 investors

Mendaera builds robotic technology, including its Focalist System for robotic-guided access and procedures such as transplant biopsy, to help healthcare providers perform reproducible clinical procedures. The company serves clinicians and healthcare providers in the medical device and surgical robotics field.

4 investors

Merus develops multispecific antibodies (Biclonics and Triclonics) that bind multiple cancer antigens to treat oncology indications. The company's lead candidate, petosemtamab, is in clinical development for head and neck cancer and colorectal cancer.

4 investors

Metcela develops cell-based medicines through research and development, focused on delivering new treatments for children and people affected by rare diseases.

4 investors

Miach Orthopaedics develops implants that help the body restore its own connective tissue, with an initial focus on treating ACL tears. Its lead product is the BEAR Implant for bridge-enhanced ACL restoration, positioned in the orthopedic medical device field.

4 investors

MicroTech Medical produces the Equil patch insulin pump, a tubeless wearable pump for people managing diabetes, and references the Aidex continuous glucose monitoring system (CGMS) for real-time glucose tracking. Its products are aimed at diabetes patients seeking to manage insulin delivery and blood sugar during daily life and exercise.

4 investors

MyBiometry offers a patented at-home sensor and device that measures airway inflammation through fractional exhaled nitric oxide (FeNO) in a person's breath. The biomarker data is used to assess attack risk, medication adherence and efficacy, and exposure to environmental triggers for respiratory conditions.

4 investors

Natural Cycles offers an FDA-cleared mobile app that uses a user's body temperature data and an algorithm to predict fertile windows for hormone-free birth control and pregnancy planning. The app supports women's health across life stages from contraception through perimenopause and is certified in over 35 countries.

4 investors

nChroma Bio develops in vivo targeted delivery and genetic engineering technologies for genetic medicine applications. The company works with academic founders and institutional investors focused on advancing gene therapy treatments.

4 investors

Neopenda develops health-technology devices for neonatal care in emerging markets, specifically serving healthcare facilities in underserved populations. The company, structured as a public benefit corporation, focuses on innovative products to improve health outcomes in resource-limited settings.

4 investors

Nervonik develops peripheral nerve stimulation (PNS) systems designed for high-motion, dynamic activity, using a patented technology that adds biosensing and objective feedback to neuromodulation. The systems focus on connectivity, wearability, lead stability, and durability for medical device applications.

4 investors

NeuraLight develops AI-powered digital biomarkers for neurological diseases including Alzheimer's, Parkinson's, and multiple sclerosis. The company uses signal processing and computer vision to enable clinical assessment and disease monitoring for healthcare providers and medical institutions.

4 investors

NeuroBionics develops soft, flexible neural interface technologies for neuromodulation applications. The company translates bioelectronic devices from preclinical research toward first-in-human studies and commercialization.

4 investors

Neurofenix is a tech-enabled virtual care provider that delivers neurorehabilitation therapy to neurological patients at home, including an upper-limb program for stroke survivors. It combines dedicated therapists, gamified therapeutic activities, remote tracking devices, and a monitoring platform (NeuroPlatform) that integrates with existing healthcare systems.

4 investors

NewAmsterdam Pharma develops innovative therapies for cardiovascular disease and lipid-related conditions. The company aims to provide lipid-lowering treatments that help patients with cardiovascular risk manage their health.

4 investors

NextBiomedical develops innovative polymer-based pharmaceutical and medical device technologies designed to overcome limitations of existing therapeutics. The company specializes in adhesive polymers, polysaccharides, and microparticle formulations for controlled drug delivery and enhanced biocompatibility.

4 investors

Noema Pharma develops a late-stage portfolio of oral small molecule therapeutics for people with neurological and related disorders, targeting both orphan and larger indications with significant unmet medical needs. The company works with patients, caregivers, and healthcare professionals throughout discovery and clinical development.

4 investors

Nucleus provides genetic testing and analysis for couples planning pregnancy, screening for over 200 hereditary diseases, traits, and health conditions. For those undergoing IVF, the company offers embryo selection guidance to reduce disease risk and optimize traits including eye color, height, and intelligence.

4 investors

Numerion combines drug discovery expertise with machine learning and computational chemistry. The company applies AI to drug development.

4 investors

NuvoAir provides virtual-first specialty care for chronic cardiopulmonary and sleep conditions such as COPD, asthma, and sleep apnea, combining FDA-cleared at-home monitoring devices, personalized care plans, and remote monitoring. It serves patients, healthcare providers, and health plans, offering a value-based care model covered by over 100 U.S. health plans.

4 investors